Form 4 for LH Labcorp
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0001127602-24-003551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-06 | 2024-02-02 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | F - Tax | $221.54 | -166 | 20.6K | -0.8% | -$36.8K |
| D | 2024-02-06 | 2024-02-02 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | — | +495 | 20.8K | +2% | — |
| D | 2024-02-06 | 2024-02-02 | LH | Caveney Brian J | EVP, CMO, CSO, Pres of ED | M - OptEx | $0.00 | -495 | 14.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | F | D | 166 | $221.54 | 20,626.04 | D | — | — | (F2) Amount includes 66.4341 shares acquired on May 31, 2023 and 44.8463 shares acquired on December 29, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-02-02 | M | A | 495 | — | 20,792.04 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F2) Amount includes 66.4341 shares acquired on May 31, 2023 and 44.8463 shares acquired on December 29, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Unit | 2024-02-02 | M | D | 495 | $0.00 | 14,387 | D | — · — to — | 495 Common Stock | (F5) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Amount includes an additional 253 Restricted Stock Units resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Laboratory Corporation of America Holdings and Fortrea Holdings Inc. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F4) The Restricted Stock Units vested in three equal annual installments beginning on February 2, 2022 and are now fully vested. |